Cost-effectiveness analysis of docetaxel (Taxotere®) vs. 5-fluorouracil in combined therapy in the initial phases of breast cancer
- Martín-Jiménez, M.
- Rodríguez-Lescure, Á.
- Ruiz-Borrego, M.
- Seguí-Palmer, M.-Á.
- Brosa-Riestra, M.
ISSN: 1699-048X
Année de publication: 2009
Volumen: 11
Número: 1
Pages: 41-47
Type: Article